EUVIMEDEUVIMED entdecken
Crossref

The Protective Effect of Sodium Molybdate on Folic Acid‐Induced Chronic Kidney Injury in Rat Model: A Preclinical Investigation

Lamiaa M Ramadan iD, Eman Khalifa iD, Dina Abdel Hamid, Soad M Eweida

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.70693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Lamiaa M Ramadan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, National Research Centre, Cairo, Egypt. Hauptthemen laut MEDLINE: Molybdenum, Folic Acid, Renal Insufficiency, Chronic, Kidney. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney injury is a cosmopolitan concern of health as it is related to high morbidity and mortality. The current study was a preclinical investigation that used a rat model to study the renal protective effect of sodium molybdate (SM) against folic acid (FA)‐induced nephropathy. Chronic kidney disease (CKD) was induced in rats by a single intraperitoneal ( i.p .) injection of 250 mg/kg FA. SM orally administered at doses of 0.1 and 0.2 g/kg/day for 35 days. SM attenuated FA‐induced chronic kidney injury that demonstrated by a significant decrease in urine total proteins/24 h, serum creatinine, urea concentrations, and LDH activity, and renal MDA concentration and elevation in renal TAC and GSH content. Furthermore, renal TNF‐α, NF‐κB, caspase‐3, α‐SMA, and hydroxyproline contents significantly reduced, meanwhile renal Bcl2 significantly increased. FA‐induced histopathological alterations were mitigated. SM's renoprotective effect against FA‐induced renal injury might be attributed to its free radical scavenger, anti‐inflammatory, antiapoptotic, and/or antifibrotic mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MolybdenumFolic AcidRenal Insufficiency, ChronicKidneyAnimalsRatsMaleDisease Models, AnimalNF-kappa BTumor Necrosis Factor-alphaProto-Oncogene Proteins c-bcl-2Caspase 3ActinsRats, Wistar

Stichwörter der Autor:innen

Bcl‐2NF‐κB/TNF‐αcaspase‐3folic acidsodium molybdateα‐SMA

Substanzen

MolybdenumFolic Acidsodium molybdate(VI)NF-kappa BTumor Necrosis Factor-alphaProto-Oncogene Proteins c-bcl-2Caspase 3ActinsCasp3 protein, ratActa2 protein, rat

Autor:innen und Institutionen

  • Biochemistry Department, National Research Centre, Cairo, Egypt.
  • Medical Laboratory Department, Faculty of Applied Health Science Technology, Nile Valley University, Fayoum, Egypt.
  • Hematology and Bone Marrow Transplantation Unit, Children's University Hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

ORCID-Profile: Lamiaa M Ramadan, Eman Khalifa

Zitieren

APA

Ramadan, L. M., Khalifa, E., Hamid, D. A., & Eweida, S. M. (2026). The Protective Effect of Sodium Molybdate on Folic Acid‐Induced Chronic Kidney Injury in Rat Model: A Preclinical Investigation. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70693

Vancouver

Ramadan LM, Khalifa E, Hamid DA, Eweida SM. The Protective Effect of Sodium Molybdate on Folic Acid‐Induced Chronic Kidney Injury in Rat Model: A Preclinical Investigation. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70693

BibTeX
@article{Ramadan2026,
  author = {Ramadan, Lamiaa M and Khalifa, Eman and Hamid, Dina Abdel and Eweida, Soad M},
  title = {The Protective Effect of Sodium Molybdate on Folic Acid‐Induced Chronic Kidney Injury in Rat Model: A Preclinical Investigation},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.70693}
}
Kostenlos starten →